Cynata Therapeutics Limited (CYYNF)
OTCMKTS · Delayed Price · Currency is USD
0.2200
0.00 (0.00%)
At close: Feb 2, 2026
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of $67.74 million as of February 12, 2026. Its market cap has increased by 109.06% in one year.
Market Cap
67.74M
Enterprise Value
64.15M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22
Market Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has increased from 13.39M to 67.74M, an increase of 405.76%. That is a compound annual growth rate of 9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 67.74M | 23.96% |
| Dec 31, 2025 | 54.64M | 63.34% |
| Dec 31, 2024 | 33.45M | 118.57% |
| Dec 29, 2023 | 15.31M | -47.61% |
| Dec 30, 2022 | 29.21M | -48.55% |
| Dec 31, 2021 | 56.78M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |
| ZIVO Bioscience | 40.77M |